Safety and tolerability of new-generation anti-obesity medications: a narrative review

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

(2017) Carel W le Roux et al.   LANCET

The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study

(2017) Fatima Cody Stanford et al.   Surgery for Obesity and Related Diseases

The Current Role of Liraglutide in the Pharmacotherapy of Obesity

(2016) Georgios A. Christou et al.   Current Vascular Pharmacology

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY

(2016) W. Timothy Garvey et al.   Endocrine Practice

Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release

(2016) Bruno Halpern et al.   Expert Opinion On Drug Safety

Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial

(2016) A Blackman et al.   INTERNATIONAL JOURNAL OF OBESITY

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors

(2016) Steven E. Nissen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

(2016) Emanuele Di Angelantonio et al.   LANCET

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s

(2016) Catherine E. Thomas et al.   Obesity

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials

(2016) Neil J. Weissman et al.   Obesity

Why do we need observational studies of everyday patients in the real-life setting?: Table 1

(2015) Alexander T. Cohen et al.   EUROPEAN HEART JOURNAL SUPPLEMENTS

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

(2015) Melanie J. Davies et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmacotherapy for the management of obesity

(2015) Dhiren Patel   METABOLISM-CLINICAL AND EXPERIMENTAL

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

(2015) Xavier Pi-Sunyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and tolerability of medications approved for chronic weight management

(2015) Ken Fujioka   Obesity

Comorbidity associated with obesity in a large population: The APNA study

(2015) Elena Martin-Rodriguez et al.   Obesity Research & Clinical Practice

Next Generation of Weight Management Medications: Implications for Diabetes and CVD Risk

(2015) S. Wharton et al.   Current Cardiology Reports

Update on obesity pharmacotherapy

(2014) George A. Bray et al.   Annals of the New York Academy of Sciences

Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus

(2014) Nathaniel R. Smilowitz et al.   CIRCULATION

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study

(2014) Guangwei Li et al.   Lancet Diabetes & Endocrinology

Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

(2013) P. Hollander et al.   DIABETES CARE

Elevated body mass index as a causal risk factor for symptomatic gallstone disease: A Mendelian randomization study

(2013) Stefan Stender et al.   HEPATOLOGY

Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study

(2013) K Johansson et al.   INTERNATIONAL JOURNAL OF OBESITY

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

(2013) T A Wadden et al.   INTERNATIONAL JOURNAL OF OBESITY

Long-term Drug Treatment for Obesity

(2013) Susan Z. Yanovski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults

(2013) Louis J. Aronne et al.   Obesity

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)

(2013) Caroline M. Apovian et al.   Obesity

Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery

(2013) M. Fried et al.   OBESITY SURGERY

Use of Prescription Antiobesity Drugs in the United States

(2013) Christian Hampp et al.   PHARMACOTHERAPY

Risk of colorectal cancer after initiation of orlistat: matched cohort study

(2013) J.-L. Hong et al.   BMJ-British Medical Journal

Obesity and Severe Obesity Forecasts Through 2030

(2012) Eric A. Finkelstein et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation

(2012) Lars Wichmann Madsen et al.   ENDOCRINOLOGY

Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus

(2012) Peter A Banks et al.   GUT

Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study

(2012) Patrick M. O'Neil et al.   Obesity

A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults

(2012) David H. Winslow et al.   SLEEP

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

(2011) W Timothy Garvey et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes

(2011) R. R. Wing et al.   DIABETES CARE

Body mass index and the risk and prognosis of acute pancreatitis

(2011) Shen Hong et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

(2011) Meredith C. Fidler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

(2011) Kishore M Gadde et al.   LANCET

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)

(2011) David B. Allison et al.   Obesity

Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients

(2010) Bankole A. Johnson et al.   CURRENT PHARMACEUTICAL DESIGN

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2010) Frank L Greenway et al.   LANCET

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

(2010) Thomas A. Wadden et al.   Obesity

Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates

(2009) Eric A. Finkelstein et al.   HEALTH AFFAIRS

A proposed clinical staging system for obesity

(2009) A M Sharma et al.   INTERNATIONAL JOURNAL OF OBESITY

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Perioperative Safety in the Longitudinal Assessment of Bariatric Surgery

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

The Medical Risks of Obesity

(2009) Xavier Pi-Sunyer   POSTGRADUATE MEDICINE